Viking Therapeutics Inc

VKTXNASDAQ · USD
35.56USD0.00 (-3.24%)
127

Viking Therapeutics Inc (VKTX) Historical Volatility

VKTX 30-day historical volatility is 107%. This ranks in the 98th percentile of readings over the past year.

Read more

Tracking VKTX historical volatility helps you see how much Viking Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Viking Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor VKTX 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The VKTX 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Viking Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy.

The company was incorporated in 2012 and is headquartered in San Diego, California.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Viking Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where VKTX HV is running hot, cold, or in line. Make the VKTX 30 day historical volatility — and every other window — work for your edge instead of against it.

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of September 25, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of September 25, 2026

See how volatility has moved over time

Track VKTX historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.

Start your 14-day free trial